Synthesis and antifungal activity of coumarins and angular furanocoumarins

Bioorganic and Medicinal Chemistry

Volumn 7, Issue 9, 1999, Pages 1933-1940

  Sardari, Soroush ^a   Mori, Yoki ^b   Horita, Kiyoshi ^b   Micetich, Ronald G ^a,c   Nishibe, Sansei ^b   Daneshtalab, Mohsen ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^c NAEJA Pharmaceutical Inc   (Canada)

Author keywords

Antifungal; Coumarins; Cytotoxicity; Fungi

Indexed keywords

6 HYDROXYFURO[2,3H] 1 BENZOPYRAN 2 ONE; 8 CARBAMOYL[N (1 DECANYL)]FURO[2,3 H] 1 BENZOPYRAN 2 ONE; ANGELICIN; ANTIFUNGAL AGENT; COUMARIN DERIVATIVE; DOXORUBICIN; FLUCONAZOLE; FUROCOUMARIN DERIVATIVE; ITRACONAZOLE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; CANDIDA ALBICANS; CRYPTOCOCCUS NEOFORMANS; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; SACCHAROMYCES CEREVISIAE; STRUCTURE ACTIVITY RELATION;

ANTIFUNGAL AGENTS; ASPERGILLUS NIGER; CANDIDA ALBICANS; CELL LINE; CELL SURVIVAL; COUMARINS; CRYPTOCOCCUS NEOFORMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; SACCHAROMYCES CEREVISIAE; SPECTRUM ANALYSIS;

EID: 0032853254     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(99)00138-8     Document Type: Article

References (18)

1. Pfaller M.A., Wenzel R.P. Eur. J. Clin. Microbiol. Infect. Dis. 11:1992;287.
2. British Society for antimicrobial chemotherapy working party, Antifungal chemotherapy in patients with acquired immunodeficiency syndrome, Lancet 1992, 340, 648.
3. Grayer R.J., Harborne J.B. Phytochem. 37:1994;19.
4. Sardari, S. Ph.D. Thesis, University of Alberta. Edmonton. Canada 1998; pp 35-48.
5. Zubía E., Luis F.R., Massanet G.M., Collado I.G. Tetrahedron. 48:1992;4239.
6. Ahluwalia V.K., Prakash C., Rani N. Indian J. Chem. 15B:1977;1137.
7. Seshadri T.R., Sood M.S. J. Indian Chem. Soc. 39:1962;539.
8. Trost B.M., Fleming I., Winterfeldt E. Comprehensive Organic Synthesis. 1991;Pergamon, Oxford. Vol. 2, pp 745-747.
9. Soine T.O. J. Pharm. Sci. 53:1964;231.
10. Scheel, L. D. Microbial Toxins; Ajl, S. J., Ed.; Academic: New York, 1972; Vol. 8, pp. 47-66.
11. Jurd D.L., King J.R., Mihara K. Experientia. 26:1970;1281.
12. Knypl J.S. Nature. 200:1963;800.
13. Dini A., Ramundo E., Saturnino P., Scimone A., Stagno d'Alcontres I. Bollettino-Societa Italiana Biologia Sperimentale. 66:1992;453.
14. Bordin F., Dall'aqua F., Guiotto A. Pharmac. Ther. 52:1991;331.
15. Averbeck D., Chandra P., Biswas R.K. Radiation & Environmental Biophysics. 12:1975;241.
16. Harayama T., Nishita Y. Chem. Pharm. Bull. 44:1996;1986.
17. National Committee for Clinical Laboratory Standards, Reference Method for Broth Dilution Antifungal Susceptibility Testing for Yeasts, Proposed Standards, Document M27-P; National Committee for Clinical Laboratory Standards: Villanova, PA, 1992.
18. Hansen M.B., Nielsen S.E., Berg K. J. Immunol. Methods. 119:1989;203.